Echocardiographic features of COVID-19 patients without significant baseline cardiovascular disease
Authors:
Company:
1 Davydovskiy City Clinical Hospital of Moscow Department of Health, Moscow, Russian Federation
2 Department of Cardiology of Moscow State University of Medicine and Dentistry named after A.I. Evdokimov of Ministry of Health of the Russian Federation, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Original articles
DOI:
For citation: Yakovlev S.A., Dukhin O.A., Kalinskaya A.I., Ryzhkova E.V., Andreeva E.V., Lebedeva A.Yu., Vasilieva E.Yu., Shpektor A.V. Echocardiographic features of COVID-19 patients without significant baseline cardiovascular disease. Creative Cardiology. 2021; 15 (3): 367–76 (in Russ.). DOI: 10.24022/1997-3187-2021-15-3-367-376
Received / Accepted: 28.07.2021 / 25.08.2021
Keywords: COVID-19 echocardiography global longitudinal strain
Abstract
Objective. To assess the relationship between the severity of COVID-19 in patients without significant baseline cardiovascular pathology and various echocardiographic parameters of myocardial dysfunction.
Material and methods. 46 patients with COVID-19 were included in our study: 33 patients of moderate severity and 13 – with severe disease. On days 1 and 9 upon admission, all patients underwent an echocardiographic study with standard assessment of the both ventricles function, as well as an assessment of their global longitudinal strain (GLS). Comparison of the studied parameters was carried out both between groups of patients and within each group in dynamics.
Results. On day 1patients in the severe group had higher values of the systolic gradient on the tricuspid valve (22.0 [21.0; 26.0] vs 30.0 [24.0; 34.5] mm Hg, p = 0.02), systolic excursion of the plane of the tricuspid ring (2.3 [2.1; 2.4] vs 2.0 [1.9; 2.2] mm, p = 0.016), E/e' ratio (9.5 [7.7; 8.9] vs 7.5 [6.8; 9.3], p = 0.03). At day 9 among patients in the severe group, there was a decrease in end-diastolic (111.0 [100.0; 120.0] vs 100.0 [89.0; 105.0] ml, p = 0.03) and of end-systolic (35.5 [32.0; 41, 2] vs 28.0 [25.0; 31.8] ml, p < 0.01) volumes of the left ventricle. There was a decrease in GLS of the both ventricles compared to general accepted values. In dynamics, there was an increase in the GLS of the right ventricle in both groups, but it was more pronounced among severe group of patients (day 1 –18.5 [–15.2; –21.1] vs –20.2 [–15.8.1; –21.1] %, p = 0.03). The troponin levels were in the normal range.
Conclusion. In COVID-19 patients without significant baseline cardiovascular pathology, there is a transient decrease in longitudinal strain of both ventricles, even in the absence of clinical and laboratory signs of acute myocardial injury.
References
- Gattinoni L., Chiumello D., Caironi P., Busana M., Romitti F., Brazzi L. et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Int. Care Med. 2020; 46: 1099–102. DOI: 10.1007/s00134-020-06033-2
- Maev I., Shpektor A., Vasilyeva E., Manchurov V., Andreev D. Novel coronavirus infection COVID-19: extrapulmonary manifestations. Ter. Arkh. 2020; 92: 4–11. DOI: 10.26442/00403660.2020.08.000767
- Adukia S., Ruhatiya R., Maheshwarappa H., Manjunath R.B., Jain G.N. Extrapulmonary features of COVID-19: a concise review. Indi. J. Crit. Care Med. 2020; 24: 575–80. DOI: 10.5005/jp-journals10071-23476
- Nishiga M., Wang D., Han Y., Lewis D., Wu J. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020; 17: 543–58. DOI: 10.5005/jp-journals-10071-23476
- Tajbakhsh A., Gheibi H., Taghizadeh H., Akbari A., Inabadi M., Savardashtaki A. et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev. Anti. Infect. Ther. 2021; 19: 345–57. DOI: 10.1080/14787210.2020.1822737
- Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. et al. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Hear Rhythm. 2020; 17: 1463–71. DOI: 10.1016/j.hrthm.2020.05.001
- Castiello T., Georgiopoulos G., Finocchiaro G., Gherardo C., Monaco G., Delialis A. et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail. Rev. 2021; 1-1. DOI: 10.1007/s10741-021-10087-9
- Chen B., Shi N., Wu C., An D., Shi Y., Wesemann L. et al. Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging. Eur. Hear J. Cardiovasc. Imaging. 2021. DOI: 10.1093/ehjci/jeab042
- Inciardi R., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. et al. Cardiac Involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 819–24. DOI: 10.1001/jamacardio.2020.1096
- Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5 (7): 802–10. DOI: 10.1001/jamacardio.2020.0950
- Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020; 311: 116–21. DOI: 10.1016/j.ijcard.2020.03.087
- Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I. et al. The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) – a systematic echocardiographic study. Circulation. 2020; 142 (4): 342–53. DOI: 10.1161/circulationaha.120.047971
- Dweck M., Bularga A., Hahn R., Bing R., Lee K., Chapman A. et al. Global evaluation of echocardiography in patients with COVID-19. Eur. Heart J. Cardiovasc. Imaging. 2020; 21: 949–58. DOI: 10.1093/ehjci/jeaa178
- Potter E., Marwick T. Assessment of Left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc. Imaging. 2018; 11: 260–74. DOI: 10.1016/j.jcmg.2017.11.017
- Li Y., Li H., Zhu S., Xie Y., Wang B., He L. et al. Prognostic Value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc. Imaging. 2020; 13 (11): 2287–99. DOI: 10.1016/j.jcmg.2020.04.014
- Park J., Kim Y., Pereira J., Hennessey K., Faridi K., McNamara R. et al. Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19. Am. Heart J. Plus. Cardiol. Res. Pract. 2021; 100018. DOI: 10.1016/j.ahjo.2021.100018
- Badano L., Kolias T., Muraru D., Abraham T., Aurigemna G., Edvardsen T. et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur. Heart J. Cardiovasc. Imaging. 2018; 19 (6): 591–600. DOI: 10.1093/ehjci/jey042
- Capotosto L., Nguyen B., Ciardi M., Mastroianni C., Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography. 2020; 37 (9): 1454–64. DOI: 10.1111/echo.14834
- Puntmann V., Carerj M., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of Cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 5 (11): 1265–73. DOI: 10.1001/jamacardio.2020.3557
- Aikawa T., Takagi H., Ishikawa K., Kuno T. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: An insight from a meta-analysis. J. Med. Virol. 2021; 93 (1): 51–5. DOI: 10.1002/jmv.26108
- Giustino G., Pinney S., Lala A., Reddy V., Johnston-Cox H., Mechanick et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J. Am. Coll. Cardiol. 2020; 76 (17): 2011–23. DOI: 10.1016/j.jacc.2020.08.059
- Bernal-Torres W., Herrera-Escandón ′ A., HurtadoRivera M., Plata-Mosquera C., Savarese G., David S. et al. COVID-19 fulminant myocarditis: a case report. Eur. Hear J. Case Rep. 2020; 4 (FI1). DOI: 10.1093/ehjcr/ytaa212
- Craver R., Huber S., Sandomirsky M., McKenna D., Schieffelin J., Finger L. Fatal Eosinophilic myocarditis in a healthy 17-year-old male with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2c). Fetal Pediatr. Pathol. 2020; 39 (3): 263–8. DOI: 10.1080/15513815.2020.1761491
- Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. et al. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Hear Rhythm. 2020; 17 (9): 1463–71. DOI: 10.1016/j.hrthm.2020.05.001
- orris D., Krisper M., Nakatani S., Kohncke C., Otsiji Y., Belyavskiy E. et al. Normal range and usefulness of right ventricular systolic strain to detect subtle right ventricular systolic abnormalities in patients with heart failure: a multicentre study. Eur. Heart J. Cardiovasc. Imaging. 2017; 18 (2): 212–23. DOI: 10.1093/ehjci/jew011
- Yingchoncharoen T., Agarwal S., Popović Z., Marwick T. Normal ranges of left ventricular strain: a meta-analysis. J. Am. Soc. Echocardiogr. 2013; 26 (2): 185–91. DOI: 10.1016/j.echo.2012.10.008
- Fahim O., Fawzi A., Beshay M., Yousif M. Study of the relation between speckle tracking echocardiography and BODE index in patients with chronic obstructive pulmonary disease. Egypt. J. Chest Dis. Tuberc. 2020; 69 (3): 524. DOI: 10.4103/ejcdt.ejcdt_168_19
- Namana V., Siddiqui S., Balasubramanian R., Sarasam R., Shetty V. Saddle pulmonary embolism: Right ventricular strain an indicator for early surgical approach. Oxford Med. Case Reports. 2016; 2016 (6): 130–4. DOI: 10.1093/omcr/omw045
- Fayssoil A., Mustafic H., Mansencal N. The right ventricle in COVID-19 patients. J. Clean. Prod. 2020; 130: 166. DOI: 10.1016/j.amjcard.2020.06.007
- Park J., Banerjee S., Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm. Circ. 2020; 10 (3): 1–7. DOI: 10.1177/2045894020936660
- Golukhova Е., Slivneva I., Rybka M., Mamalyga M., Marapov D., Klyuchnikov I. Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19. Kardiologia. 2020; 60 (11): 16–29. DOI: 10.18087/cardio.2020.11.n1303
- Minhas A., Scheel P., Garibaldi B., Liu G., Horton M., Jennings M. et al. Takotsubo syndrome in the setting of COVID-19. JACC Case Reports. 2020; 2 (9): 1321–5. DOI: 10.1016/j.jaccas.2020. 04.023
- Babapoor-Farrokhran S., Rasekhi R., Gill D., Babapoor S., Amanullah A. Arrhythmia in COVID-19. SN Compr. Clin. Med. 2020; 2 (9): 1–6. DOI: 10.1007/s42399-020-00454-2
- Gasso L., Maneiro M., Sarnago F., Solis J., Garcia Tejada J. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection. Eur. Heart J. 2020; 41 (32): 3100–1. DOI: 10.1093/eurheartj/ehaa400
- Hua A., O’Gallagher K., Sado D., Byrne J. Lifethreatening cardiac tamponade complicating myopericarditis in COVID-19. Eur. Heart J. 2020; 41 (22): 2130. DOI: 10.1093/eurheartj/ehaa253
About Authors
- Sergey A. Yakovlev, Ultrasonic Diagnostics Physician; ORCID
- Oleg A. Dukhin, Postgraduate; ORCID
- Anna I. Kalinskaya, Associate Professor, Cand. Med. Sci., Head of Department; ORCID
- Evgeniya V. Ryzhkova, Ultrasonic Diagnostics Physician; ORCID
- El’za V. Andreeva, Ultrasonic Diagnostics Physician; ORCID
- Anastasiya Yu. Lebedeva, Dr. Med. Sci., Professor, Deputy Chief Physician; ORCID
- Elena Yu. Vasilieva, Dr. Med. Sci., Professor, Head of Laboratory, Chief Physician; ORCID
- Aleksander V. Shpektor, Dr. Med. Sci., Professor, Corresponding Member of RAS, Chief of Chair, Head of the University Clinic of Cardiology; ORCID